HSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway

FEBS Letters

Volumn 582, Issue 29, 2008, Pages 4023-4031

  Liu, Xin Yu ^a   Seh, Cheah Chen ^a   Cheung, Peter C F ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Inflammation; Interleukin 1; Lipopolysaccharide; Protein kinase; Tumor necrosis factor

Indexed keywords

CELL CYCLE PROTEIN 37; HEAT SHOCK PROTEIN 90; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TANESPIMYCIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BENZOQUINONES; CELL CYCLE PROTEINS; CHAPERONINS; ENZYME ACTIVATION; ENZYME STABILITY; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; LACTAMS, MACROCYCLIC; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE KINASES; PROTEIN FOLDING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 56649115777     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.10.053     Document Type: Article

References (25)

1. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., Lee K.Y., Bussey C., Steckel M., Tanaka N., Yamada G., Akira S., Matsumoto K., and Ghosh S. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19 (2005) 2668-2681
2. Cheung P.C., Nebreda A.R., and Cohen P. TAB3, a new binding partner of the protein kinase TAK1. Biochem J. 378 (2004) 27-34
3. Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E., and Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272 (1996) 1179-1182
4. Komatsu Y., Shibuya H., Takeda N., Ninomiya-Tsuji J., Yasui T., Miyado K., Sekimoto T., Ueno N., Matsumoto K., and Yamada G. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119 (2002) 239-249
5. Mendoza H., Campbell D.G., Burness K., Hastie J., Ronkina N., Shim J.H., Arthur J.S., Davis R.J., Gaestel M., Johnson G.L., Ghosh S., and Cohen P. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem. J. 409 (2007) 711-722
6. Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., Ninomiya-Tsuji J., and Matsumoto K.T. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell. 5 (2000) 649-658
7. Ishitani T., Takaesu G., Ninomiya-Tsuji J., Shibuya H., Gaynor R.B., and Matsumoto K. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 22 (2003) 6277-6288
8. Kanayama A., Seth R.B., Sun L., Ea C.K., Hong M., Shaito A., Chiu Y.H., Deng L., and Chen Z.J. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell. 15 (2004) 535-548
9. Jin G., Klika A., Callahan M., Faga B., Danzig J., Jiang Z., Li X., Stark G.R., Harrington J., and Sherf B. Identification of a human NF-kappaB-activating protein, TAB3. Proc. Natl. Acad. Sci. USA 101 (2004) 2028-2033
10. Akira S. Toll-like receptor signaling. J. Biol. Chem. 278 (2003) 38105-38108 (Review)
11. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
12. Adhikari A., Xu M., and Chen Z.J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26 (2007) 3214-3226 (Review)
13. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398 (1999) 252-256
14. Lee J., Mira-Arbibe L., and Ulevitch R.J. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukocyte Biol. 68 (2000) 909-915
15. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., Matsumoto K., Takeuchi O., and Akira S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6 (2005) 1087-1095
16. Caplan A.J., Mandal A.K., and Theodoraki M.A. Molecular chaperones and protein kinase quality control. Trends Cell Biol. 17 (2007) 87-92 (Review)
17. da Rocha Dias S., Friedlos F., Light Y., Springer C., Workman P., and Marais R. Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 65 (2005) 10686-10691
18. Schulte T.W., An W.G., and Neckers L.M. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signaling pathway. Biochem. Biophys. Res. Commun. 239 (1997) 655-659
19. Vanden Berghe T., Kalai M., van Loo G., Declercq W., and Vandenabeele P. Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J. Biol. Chem. 278 (2003) 5622-5629
20. De Nardo D., Masendycz P., Ho S., Cross M., Fleetwood A.J., Reynolds E.C., Hamilton J.A., and Scholz G.M. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors. J. Biol. Chem. 280 (2005) 9813-9822
21. Chen G., Cao P., and Goeddel D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell. 9 (2002) 401-410
22. Decker T. Sepsis: avoiding its deadly toll. J. Clin. Invest. 113 (2004) 1387-1389
23. Bertelsen M., and Sanfridson A. TAB1 modulates IL-1alpha mediated cytokine secretion but is dispensable for TAK1 activation. Cell Signal. 19 (2007) 646-657
24. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., and Pearl L.H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42 (1999) 260-266
25. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 (1987) 2745-2752